Microcolumn gel cards are diagnostic tools used primarily in immunohematology for blood typing, antibody screening, and cross-matching. These cards utilize a microcolumn gel technology that simplifies and enhances the accuracy of blood tests by separating and identifying blood cells and antibodies.

The global Microcolumn Gel Cards market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Microcolumn Gel Cards Industry Forecast” looks at past sales and reviews total world Microcolumn Gel Cards sales in 2023, providing a comprehensive analysis by region and market sector of projected Microcolumn Gel Cards sales for 2024 through 2030.

This Insight Report provides a comprehensive analysis of the global Microcolumn Gel Cards landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Microcolumn Gel Cards portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microcolumn Gel Cards market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microcolumn Gel Cards and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity.

The Gel Card Method is based on the principles of agglutination and hemagglutination. Agglutination is the clumping together of particles – in this case, red blood cells (RBCs). The RBCs will agglutinate when mixed with sera containing the corresponding antibodies. The degree of agglutination in the microtubes within the gel card is then used to determine the blood group.

This report presents a comprehensive overview, market shares, and growth opportunities of Microcolumn Gel Cards market by product type, application, key manufacturers and key regions and countries.

• Blood Grouping Forward and Reverse Test
• Cross Match Test
• Other

• Hospitals
• Research Centers
• Laboratory
• Others

This report also splits the market by region:

• United States
• Canada
• Mexico
• Brazil

• China
• Japan
• Korea
• Southeast Asia
• India
• Australia

• Germany
• France
• UK
• Italy
• Russia

• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Grifols
• Bio-Rad
• Ortho Clinical Diagnostics (QuidelOrtho)
• Turklab
• Tulip Diagnostics (PerkinElmer)
• Redcell Biotechnology
• Dia Pro Tıbbi Ürünler
• Aikang MedTech
• Tianjin Dexiang Biotech
• POLYRICHE BIOTECH
• Hubei Longtime Biological
• Singapore BioSciences

1. What is the 10-year outlook for the global Microcolumn Gel Cards market?
2. What factors are driving Microcolumn Gel Cards market growth, globally and by region?
3. Which technologies are poised for the fastest growth by market and region?
4. How do Microcolumn Gel Cards market opportunities vary by end market size?
5. How does Microcolumn Gel Cards break out by Type, by Application?